share_log

多瑞医药(301075.SZ):拟以0万元受让红熙医疗51%股权(未实缴)

Dorui Pharmaceutical (301075.SZ): Plans to transfer 51% of Hongxi Medical's shares for $0.0,000 (unpaid)

Gelonghui Finance ·  Jan 17 02:48

Gelonghui, January 17丨Dorui Pharmaceutical (301075.SZ) announced that in order to further enrich the company's business layout and create new profit growth points, Tibet Dorui Pharmaceutical Co., Ltd. recently signed an “Investment Cooperation Agreement”. The company took over the shares of Hongxi Medical Technology (Tianjin) Co., Ltd. (“Hongxi Medical” for short, the “Target Company”) held by Li Zhanbing, Tian Bin, Zhang Hengrui, and Xiong Rongliang with a registered capital of 5.1 million yuan (unpaid). The company will invest 5.1 million yuan in Hongxi Medical to fulfill the obligation to pay the capital. After the equity transfer was completed, the company held 51% of Hongxi Medical's shares, and Hongxi Medical is the company's holding subsidiary.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment